Skip to content

Next Generation Glaucoma Treatment

Implant-Free, Excimer Laser Technology

Understanding Glaucoma

Glaucoma is a disease of high pressure inside the eye that is caused by fluid build-up. Eye fluid helps keep the eye healthy, but when the fluid cannot exit or drain, eye pressure goes up. High intraocular pressure (IOP) damages the nerve at the back of the eye, resulting in vision loss over time.

Currently, the only way to limit the effects of glaucoma progression on vision is to lower the pressure inside the eye. Usually, a combination of prescription eye drops, implants, or surgery that removes tissue is used to achieve this.

In a healthy eye, fluid (aqueous humor) is able to flow freely into the drainage canal.
In an eye with glaucoma, the drainage canal is blocked which causes a build-up of fluid. This leads to increased pressure inside the eye which can eventually damage the optic nerve.
Play Video

A New Approach with ELIOS

The ELIOS procedure is an innovative glaucoma treatment that can be performed at the same time as cataract surgery. The procedure preserves the trabecular meshwork, is broadly adoptable by surgeons, and does not require an implant.

By using excimer laser light technology to create microscopic openings in the trabecular meshwork, ELIOS is designed to facilitate outflow of aqueous. ELIOS has been CE-marked in Europe and is currently undergoing investigational trials in the United States.

The Interventional Glaucoma Podcast

Join global thought leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma; an inspiring and thought-provoking mindset that prioritizes patient-centered care and challenges ophthalmologists to rethink their treatment strategies.

Our Mission: Addressing an Unmet Need

Cataract surgery is the most routinely performed surgery in the world with approximately 32 million procedures expected to be performed this year.1 Up to 20% of patients who need cataract surgery also have glaucoma or ocular hypertension.2 However, even though cataract surgery provides an optimal window for glaucoma treatment, it has not become a routine consideration for cataract patients.

At ELIOS, we see an opportunity to address one of the most common causes of blindness in the world during the most commonly performed surgical procedure in the world. Our goal is to make combining cataract and glaucoma treatment the new standard of care.

Elios Vision Advisory Boards

Our commercial and medical advisory boards are composed of well-respected surgeons who are active in glaucoma care and management and in researching this disease to discover the best treatments.

Commercial Advisory Board

Sahar Bedrood, MD, PhD

Advanced Vision Care

John Berdahl, MD

Vance Thompson Vision

Eric Donnenfeld, MD

Ophthalmic Consultants of Long Island & Connecticut

Christine Funke, MD

Barnet Dulaney Perkins Eye Center

Cathleen McCabe, MD

The Eye Associates

Robert Weinstock, MD

Eye Institute of West Florida

William Wiley, MD

Cleveland Eye Clinic

Blake Williamson, MD

Williamson Eye Center

Gary Wortz, MD

Commonwealth Eye Surgery

Elizabeth Yeu, MD

Virginia Eye Consultants

Medical Advisory Board

Ike K. Ahmed, MD

University of Toronto
Moran Eye
Medical Monitor

Louis B. Cantor, MD

Indiana University

Ian Conner, MD, PhD

University of Pittsburgh

Nathan Radcliffe, MD

New York Eye Surgery Center

Thomas Samuelson, MD

Minnesota Eye Care Consultants

Manjool Shah, MD

NYU Langone Eye Center

Arsham Sheybani, MD

Washington University in St. Louis


Caution: Investigational Device

You are about to access Elios Vision’s online platform for users within the United States. The ELIOS procedure is limited by federal (or United States) law to investigational use. ELIOS is not currently approved for use in the United States.